Europe Endothelin Receptor Antagonist Market Research Report Forecast 2017 to 2022

December 2017 | 124 pages | ID: EAF7BDF457CEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Europe Endothelin Receptor Antagonist Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Endothelin Receptor Antagonist industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Endothelin Receptor Antagonist market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Endothelin Receptor Antagonist Market Analysis by Countries:
Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:
Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.

Europe Endothelin Receptor Antagonist Market Analysis by Product:
Type 1
Type 2
Type 3

Europe Endothelin Receptor Antagonist Market Analysis by Application:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 ENDOTHELIN RECEPTOR ANTAGONIST MARKET OVERVIEW

1.1 Product Overview and Scope of Endothelin Receptor Antagonist
1.2 Classification of Endothelin Receptor Antagonist
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Endothelin Receptor Antagonist
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Endothelin Receptor Antagonist Market States Status and Prospect (2012-2022) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Endothelin Receptor Antagonist (2012-2022)
  1.5.1 Europe Endothelin Receptor Antagonist Sales and Growth Rate (2012-2022)
  1.5.2 Europe Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)

2 EUROPE ECONOMIC IMPACT ON ENDOTHELIN RECEPTOR ANTAGONIST INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURING COST ANALYSIS

3.1 Endothelin Receptor Antagonist Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Endothelin Receptor Antagonist Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
4.4 Downstream Buyers

5 EUROPE ENDOTHELIN RECEPTOR ANTAGONIST MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Endothelin Receptor Antagonist Market Competition by Manufacturers
  5.1.1 Europe Endothelin Receptor Antagonist Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Endothelin Receptor Antagonist Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Endothelin Receptor Antagonist (Volume and Value) by Type
  5.2.1 Europe Endothelin Receptor Antagonist Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
5.3 Europe Endothelin Receptor Antagonist (Volume and Value) by Countries
  5.3.1 Europe Endothelin Receptor Antagonist Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Endothelin Receptor Antagonist Revenue and Market Share by Countries (2012-2017)
5.4 Europe Endothelin Receptor Antagonist (Volume) by Application

6 GERMANY ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Endothelin Receptor Antagonist Sales and Value (2012-2017)
  6.1.1 Germany Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  6.1.2 Germany Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
6.2 Germany Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
6.3 Germany Endothelin Receptor Antagonist Sales and Market Share by Type
6.4 Germany Endothelin Receptor Antagonist Sales and Market Share by Application

7 FRANCE ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

7.1 France Endothelin Receptor Antagonist Sales and Value (2012-2017)
  7.1.1 France Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  7.1.2 France Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  7.1.3 France Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
7.2 France Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
7.3 France Endothelin Receptor Antagonist Sales and Market Share by Type
7.4 France Endothelin Receptor Antagonist Sales and Market Share by Application

8 UK ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

8.1 UK Endothelin Receptor Antagonist Sales and Value (2012-2017)
  8.1.1 UK Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  8.1.2 UK Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  8.1.3 UK Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
8.2 UK Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
8.3 UK Endothelin Receptor Antagonist Sales and Market Share by Type
8.4 UK Endothelin Receptor Antagonist Sales and Market Share by Application

9 RUSSIA ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Endothelin Receptor Antagonist Sales and Value (2012-2017)
  9.1.1 Russia Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  9.1.2 Russia Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
9.2 Russia Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
9.3 Russia Endothelin Receptor Antagonist Sales and Market Share by Type
9.4 Russia Endothelin Receptor Antagonist Sales and Market Share by Application

10 ITALY ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Endothelin Receptor Antagonist Sales and Value (2012-2017)
  10.1.1 Italy Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  10.1.2 Italy Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
10.2 Italy Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
10.3 Italy Endothelin Receptor Antagonist Sales and Market Share by Type
10.4 Italy Endothelin Receptor Antagonist Sales and Market Share by Application

11 SPAIN ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Endothelin Receptor Antagonist Sales and Value (2012-2017)
  11.1.1 Spain Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  11.1.2 Spain Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
11.2 Spain Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
11.3 Spain Endothelin Receptor Antagonist Sales and Market Share by Type
11.4 Spain Endothelin Receptor Antagonist Sales and Market Share by Application

12 BENELUX ENDOTHELIN RECEPTOR ANTAGONIST (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Endothelin Receptor Antagonist Sales and Value (2012-2017)
  12.1.1 Benelux Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
12.2 Benelux Endothelin Receptor Antagonist Sales and Market Share by Manufacturers
12.3 Benelux Endothelin Receptor Antagonist Sales and Market Share by Type
12.4 Benelux Endothelin Receptor Antagonist Sales and Market Share by Application

13 EUROPE ENDOTHELIN RECEPTOR ANTAGONIST MANUFACTURERS ANALYSIS

13.1 Actelion Pharmaceuticals Ltd.
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 United Therapeutics Corporation
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Gilead sciences
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Bayer AG
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 SteadyMed Ltd.
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 GlaxoSmithKline plc
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Pfizer Inc.
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Reata Pharmaceuticals Inc.
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Arena Pharmaceuticals Inc.
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE ENDOTHELIN RECEPTOR ANTAGONIST MARKET FORECAST (2017-2022)

15.1 Germany Market Forecast (2017-2022)
15.2 France Market Forecast (2017-2022)
15.3 UK Market Forecast (2017-2022)
15.4 Russia Market Forecast (2017-2022)
15.5 Italy Market Forecast (2017-2022)
15.6 Spain Market Forecast (2017-2022)
15.7 Benelux Market Forecast (2017-2022)
15.8 Europe Endothelin Receptor Antagonist Market Forecast by Type (2017-2022)
15.9 Europe Endothelin Receptor Antagonist Market Forecast by Application (2017-2022)

16 APPENDIX

List Of Tables

LIST OF TABLES

Figure Picture of Endothelin Receptor Antagonist
Table Classification of Endothelin Receptor Antagonist
Figure Europe Sales Market Share of Endothelin Receptor Antagonist by Type in 2016
Table Application of Endothelin Receptor Antagonist
Figure Europe Sales Market Share of Endothelin Receptor Antagonist by Application in 2016
Figure Germany Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure France Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure UK Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Russia Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Italy Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Spain Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Benelux Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Figure Europe Endothelin Receptor Antagonist Sales and Growth Rate (2012-2022)
Figure Europe Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2022)
Table Europe Endothelin Receptor Antagonist Sales of Key Manufacturers (2015 and 2016)
Table Europe Endothelin Receptor Antagonist Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Endothelin Receptor Antagonist Sales Share by Manufacturers
Figure 2016 Endothelin Receptor Antagonist Sales Share by Manufacturers
Table Europe Endothelin Receptor Antagonist Revenue by Manufacturers (2015 and 2016)
Table Europe Endothelin Receptor Antagonist Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table 2016 Europe Endothelin Receptor Antagonist Revenue Share by Manufacturers
Table Europe Endothelin Receptor Antagonist Sales and Market Share by Type (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales Share by Type (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure Europe Endothelin Receptor Antagonist Sales Growth Rate by Type (2012-2017)
Table Europe Endothelin Receptor Antagonist Revenue and Market Share by Type (2012-2017)
Table Europe Endothelin Receptor Antagonist Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Endothelin Receptor Antagonist by Type (2012-2017)
Figure Europe Endothelin Receptor Antagonist Revenue Growth Rate by Type (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales and Market Share by Countries (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales Share by Countries (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Countries (2012-2017)
Table Europe Endothelin Receptor Antagonist Revenue and Market Share by Countries (2012-2017)
Table Europe Endothelin Receptor Antagonist Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Endothelin Receptor Antagonist by Countries (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales and Market Share by Application (2012-2017)
Table Europe Endothelin Receptor Antagonist Sales Share by Application (2012-2017)
Figure Sales Market Share of Endothelin Receptor Antagonist by Application (2012-2017)
Figure Germany Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Germany Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Germany Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Germany Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table Germany Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table Germany Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table Germany Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table Germany Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table Germany Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Figure France Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure France Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure France Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table France Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table France Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table France Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table France Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table France Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table France Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Figure UK Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure UK Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure UK Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table UK Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table UK Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table UK Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table UK Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table UK Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table UK Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Figure Russia Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Russia Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Russia Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Russia Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table Russia Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table Russia Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table Russia Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table Russia Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table Russia Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Figure Italy Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Italy Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Italy Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Italy Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table Italy Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table Italy Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table Italy Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table Italy Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table Italy Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Figure Spain Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Spain Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Spain Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Spain Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table Spain Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table Spain Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table Spain Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table Spain Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table Spain Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Figure Benelux Endothelin Receptor Antagonist Sales and Growth Rate (2012-2017)
Figure Benelux Endothelin Receptor Antagonist Revenue and Growth Rate (2012-2017)
Figure Benelux Endothelin Receptor Antagonist Sales Price Trend (2012-2017)
Table Benelux Endothelin Receptor Antagonist Sales by Manufacturers (2015 and 2016)
Table Benelux Endothelin Receptor Antagonist Market Share by Manufacturers (2015 and 2016)
Table Benelux Endothelin Receptor Antagonist Sales by Type (2015 and 2016)
Table Benelux Endothelin Receptor Antagonist Market Share by Type (2015 and 2016)
Table Benelux Endothelin Receptor Antagonist Sales by Application (2015 and 2016)
Table Benelux Endothelin Receptor Antagonist Market Share by Application (2015 and 2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table Gilead sciences Basic Information List
Table Gilead sciences Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead sciences Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure SteadyMed Ltd. Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales Market Share (2012-2017)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist
Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure Endothelin Receptor Antagonist Industrial Chain Analysis
Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2016
Table Major Buyers of Endothelin Receptor Antagonist
Table Distributors/Traders List
Figure Germany Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Germany Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Figure France Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure France Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Figure UK Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure UK Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Russia Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Italy Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Spain Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Endothelin Receptor Antagonist Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2017-2022)
Table Europe Endothelin Receptor Antagonist Sales Forecast by Type (2017-2022)
Table Europe Endothelin Receptor Antagonist Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Merck & Co. Inc